Failure of bupropion to affect prolactin or growth hormone in man

J Clin Psychiatry. 1983 May;44(5 Pt 2):209-10.

Abstract

In a double-blind crossover design, 5 male and 5 female volunteers received 5 different oral single-dose bupropion treatments (12.5 mg to 100 mg). Analyses of plasma prolactin and growth hormone levels revealed no significant drug related effects compared to placebo.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Antidepressive Agents / pharmacology*
  • Bupropion
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Female
  • Growth Hormone / blood*
  • Humans
  • Male
  • Placebos
  • Prolactin / blood*
  • Propiophenones / pharmacology*

Substances

  • Antidepressive Agents
  • Placebos
  • Propiophenones
  • Bupropion
  • Prolactin
  • Growth Hormone